TELO

Telomir Pharmaceuticals, Inc. Common Stock

1.14

USD

TELO Earnings Reports

Positive Surprise Ratio

TELO beat 2 of 4 last estimates.

50%

Next Report

Date of Next Report

May 12, 2026

Estimate for Q1 26 (Revenue/ EPS)

-$0.07

Implied change from Q4 25 (Revenue/ EPS)

Implied change from Q1 25 (Revenue/ EPS)

Telomir Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Feb 03, 2026, TELO reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.07 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.

Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.07 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Takeda Pharmaceutical Company Limited - ADR

Report Date

Jan 30, 2026 For Q3 26

Estimate

$34.44

Actual

$65.64

Surprise

+90.61%

FAQ

What were Telomir Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Telomir Pharmaceuticals, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.

How did the market react to Telomir Pharmaceuticals, Inc. Common Stock's Q4 2025 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Telomir Pharmaceuticals, Inc. Common Stock expected to report next?

The next earning report is scheduled for May 12, 2026.

What are the forecasts for Telomir Pharmaceuticals, Inc. Common Stock's next earnings report?

Based on 3 analysts, Telomir Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.07 and revenue of -- for Q1 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.